Neurology: Dopamine, Headache Red Flags and Brain Tumours | Part 1 | 神經 | OET Music

Dr Allison Lu · Pip & Barnaby · Medical English

本頁提供本曲完整英文歌詞與影片搭配的繁中醫學提示。歌詞保留原演唱文字;遇到過度簡化或舊門檻,請搭配下方提示與原始資料閱讀。這是概念學習材料,不替代個別醫療評估。

Lyrics · 完整歌詞

Within the classical model of basal ganglia function,
the direct pathway facilitates movement
while the indirect pathway restrains competing motor activity.
Dopamine from the midbrain dopaminergic nucleus excites D1 receptors on the direct pathway
and inhibits D2 receptors on the indirect one.
When these neurons degenerate, the accelerator weakens and the brake tightens,
yielding bradykinesia, cogwheel rigidity and pill-rolling rest tremor,
with Lewy bodies of alpha-synuclein as the pathological signature.

The receptor
and the rhythm of stimulation decide the side effects of treatment.
Levodopa, given with carbidopa to block peripheral decarboxylation,
is the most effective drug,
yet its short half-life stimulates the striatum in pulses,
and over years wearing-off and dyskinesia emerge.
Agonists such as pramipexole act longer and cause less dyskinesia,
but they stimulate D3 receptors in the mesolimbic reward pathway,
provoking impulse-control disorders, hallucinations, somnolence and oedema.

Entacapone prolongs each dose by inhibiting COMT,
and any D2 antagonist such as haloperidol worsens the parkinsonism.

Within the classical model of basal ganglia function,
the direct pathway facilitates movement
while the indirect pathway restrains competing motor activity.


Site and tremor type place the other movement disorders.
Carbon monoxide destroys the hypoxia-sensitive globus pallidus rather than the midbrain dopaminergic nucleus,
and delayed parkinsonism follows.
Huntington's disease, a CAG repeat disorder with caudate atrophy,
produces early chorea that recedes late as dystonia and akinesia replace it.
Wilson's disease is suspected under forty when tremor
or parkinsonism accompanies liver disease or psychiatric change,
and a Kayser-Fleischer ring, low caeruloplasmin and high urinary copper confirm it.

Headache assessment begins by excluding a secondary cause,
and every SNOOP flag has a mechanism.
Systemic features suggest infection or vasculitis; deficits or papilloedema suggest a mass.
A thunderclap onset means a ruptured vessel until subarachnoid haemorrhage is excluded.
New headache after fifty raises giant cell arteritis,
which demands corticosteroids before biopsy.
Orthostatic headache with diffuse dural enhancement is intracranial hypotension,
whereas an obese young woman with papilloedema
and a raised opening pressure has idiopathic intracranial hypertension.

Among primary headaches, migraine arises from trigeminovascular activation with CGRP release,
and its aura is cortical spreading depression;
cluster headache follows the hypothalamic clock and the trigeminal autonomic reflex.
Triptans, agonists at 5-HT1B and 5-HT1D receptors,
constrict meningeal vessels and suppress CGRP release,
but coronary disease and uncontrolled hypertension forbid them.
Cluster attacks respond to high-flow oxygen and verapamil prevents them,
whereas migraine prevention uses propranolol, topiramate, valproate or amitriptyline, never carbamazepine,
which belongs to trigeminal neuralgia.

A tumour announces itself through raised pressure from its mass,
deficits from local destruction and seizures from cortical irritation.
Growth rate decides which comes first,
so slow low-grade gliomas present with seizures more often than glioblastoma,
which destroys and compresses.
Meningioma,
arising from arachnoid cap cells outside the brain with a dural tail,
is the commonest primary intracranial tumour.
Vestibular schwannoma grows from the vestibular nerve;
bilateral tumours define neurofibromatosis type 2,
and surgery most often injures the facial nerve.

Within the classical model of basal ganglia function,
the direct pathway facilitates movement
while the indirect pathway restrains competing motor activity.

Medical Notes · 醫學學習提示

  1. 基底核經典模型:幫助理解動作選擇
  2. 直接路徑促進選定動作
  3. 間接路徑抑制競爭動作;實際迴路更複雜
  4. 黑質多巴胺作用於直接路徑 D1 受體
  5. 多巴胺抑制間接路徑的 D2 受體神經元
  6. 黑質多巴胺神經元退化,動作促進減少
  7. 動作遲緩、僵硬與靜止顫抖是重要線索
  8. 路易氏體與 α 突觸核蛋白聚集相關
  9. 受體選擇影響治療作用與副作用
  10. 藥物刺激模式也影響長期運動波動
  11. 卡比多巴減少左旋多巴的周邊代謝
  12. 左旋多巴能有效改善帕金森運動症狀
  13. 短效藥物造成脈衝式的多巴胺刺激
  14. 長期可能出現藥效消退與異動症
  15. 致效劑初期異動症較少;仍需權衡其他風險
  16. 獎賞迴路的多巴胺刺激可能影響行為
  17. 注意衝動控制、幻覺、嗜睡與水腫
  18. 恩他卡朋抑制 COMT,延長左旋多巴作用
  19. 氟哌啶醇等多巴胺阻斷藥可加重症狀
  20. 記憶口訣:基底核調節動作的選擇
  21. 直接路徑協助啟動選定動作
  22. 間接路徑抑制競爭動作
  23. 病灶位置與顫抖型態協助鑑別
  24. 一氧化碳常傷蒼白球,也可傷白質等區域
  25. 中毒後可能延遲出現運動與認知障礙
  26. 亨丁頓病:CAG 重複擴增與尾狀核萎縮
  27. 病程後期可轉為肌張力不全與動作減少
  28. 年輕患者須想到威爾森病;不限四十歲以下
  29. 神經症狀合併肝病或精神改變是線索
  30. 角膜環、銅代謝與遺傳檢驗須綜合判讀
  31. 新發頭痛先評估次發性原因
  32. SNOOP 警訊引導檢查,不能單獨確診
  33. 全身症狀、神經缺損與視乳頭水腫皆需評估
  34. 雷擊樣頭痛須緊急排除蛛網膜下腔出血
  35. 五十歲後新發頭痛須想到巨細胞動脈炎
  36. 高度懷疑時立即治療,不等切片才給類固醇
  37. 姿勢性頭痛與硬腦膜增強提示低顱壓
  38. 肥胖與視乳頭水腫是高顱壓線索
  39. 特發性高顱壓仍須排除腫瘤與靜脈血栓
  40. 偏頭痛涉及三叉血管系統與 CGRP
  41. 先兆與皮質擴散性去極化相關
  42. 叢集性頭痛涉及下視丘節律與自主反射
  43. 曲普坦作用於 5-HT1B/1D 受體
  44. 調節顱內血管與三叉神經胜肽釋放
  45. 冠心病及未控制高血壓者須避免曲普坦
  46. 叢集急性發作可用氧氣;維拉帕米須監測心電圖
  47. 偏頭痛預防依個人選藥,須特別評估妊娠風險
  48. 卡馬西平常用於三叉神經痛,非典型偏頭痛預防藥
  49. 腫瘤占位可使顱壓上升;圖示為腦膜瘤
  50. 局部功能障礙或癲癇也可能是表現
  51. 症狀先後同時受生長速度與位置影響
  52. 低級別膠質瘤常以癲癇表現;此圖是正常腦概念
  53. 膠質母細胞瘤可快速浸潤與造成壓迫
  54. 腦膜瘤通常起源於腦膜的蛛網膜帽細胞
  55. 常為腦外軸腫瘤;硬腦膜尾徵並非專一
  56. 腦膜瘤是常見的原發顱內腫瘤
  57. 前庭神經鞘瘤源於第八腦神經的前庭分支
  58. 雙側腫瘤是 NF2 相關神經鞘瘤病的重要特徵
  59. 手術須保護顏面神經;實際風險因腫瘤而異
  60. 回顧基底核經典模型,避免視為完整迴路圖

References